dual immune checkpoint blockers (Anaeropharma Science)

N/A

Report date: 2025/03/19 11:37:33

Base Information

Drug Namedual immune checkpoint blockers (Anaeropharma Science)

Drug Alias Namedual targeting anti-PD-1/anti-CTLA4 antibodies (Anaeropharma Science)dual CTLA-4 checkpoint inhibitor/PD-1 checkpoint inhibitor (Anaeropharma Science)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody

Mechanisms of ActionProgrammed cell death protein 1 blockersCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors

TargetsProgrammed cell death protein 1Cytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsImmune System DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsYes

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAnaeropharma Science Inc

China Registration ClassN/A

Develop Information

Active CompaniesAnaeropharma Science Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A